Idiopathic normal pressure hydrocephalus: associations between CSF biomarkers, clinical symptoms, and outcome after shunt surgery
- PMID: 40389949
- PMCID: PMC12087190
- DOI: 10.1186/s12987-025-00661-w
Idiopathic normal pressure hydrocephalus: associations between CSF biomarkers, clinical symptoms, and outcome after shunt surgery
Abstract
Background: The neurochemical alterations in cerebrospinal fluid (CSF) associated with the typical symptomatology in idiopathic normal pressure hydrocephalus (iNPH) and their association with outcome after shunt surgery are unsettled.
Aim: To explore associations between concentrations of CSF biomarkers reflecting amyloid- and tau pathology, neuronal degeneration as well as astrocytic activation and the characteristic symptomatology in iNPH and to examine whether these biomarkers can predict the postoperative outcome in all patients and in patients without evidence of Alzheimer's disease (AD) pathology.
Methods: This explorative study included 81 patients diagnosed with iNPH at the Hydrocephalus research unit, Sahlgrenska. Symptoms were assessed using the iNPH-scale and standardized clinical tests measuring gait, balance, cognition and urinary incontinence before and median 8 months after shunt surgery. Pre-operative lumbar CSF concentrations of Aβ38, Aβ40, Aβ42, ratio Aβ42/Aβ40, sAPPα, sAPPβ, T-tau, P-tau, MCP-1, and NFL were analyzed. A low Aβ42/Aβ40 ratio defined patients with AD pathology. Correlation and regression analyses between biomarker concentrations and clinical symptoms at baseline as well as postoperative change in symptoms after surgery, were performed.
Results: Higher NFL correlated with more pronounced impairment in all clinical tests, i.e. included measures of gait, balance, cognition and urinary incontinence (rp=0.25-0.46, p < 0.05). Higher T-tau and P-tau correlated with poorer performance in cognitive tests (rp=0.26-0.39, p < 0.05). No biomarker could differentiate between improved and unimproved patients in the whole sample or in AD-pathology negative patients. Low ratio Aβ42/Aβ40 lacked predictive value. A higher preoperative P-tau was weakly correlated with less pronounced overall clinical improvement (rp = -0.238, p = 0.036).
Conclusions: Axonal degeneration, as indicated by elevated NFL, is probably involved in the generation of the full iNPH tetrade of symptoms and tau pathology more specifically with iNPH cognitive impairment. No CSF biomarker could identify shunt responders. CSF evidence of Alzheimer pathology should not be used to exclude patients from shunt surgery.
Keywords: Biomarkers; CSF; Cerebrospinal fluid; Idiopathic normal pressure hydrocephalus; Outcome; Symptoms.
© 2025. The Author(s).
Conflict of interest statement
Declarations. Ethics approval and consent to participate: This study was conducted in accordance with the Declaration of Helsinki and was approved by the Regional Ethical Review Board in Gothenburg (DNR 020 − 07). Written informed consent to inclusion in the study was given by all patients or their next of kin. Consent for publication: Not applicable. Competing interests: The authors declare no competing interests.
Figures
Similar articles
-
Time Trends of Cerebrospinal Fluid Biomarkers of Neurodegeneration in Idiopathic Normal Pressure Hydrocephalus.J Alzheimers Dis. 2021;80(4):1629-1642. doi: 10.3233/JAD-201361. J Alzheimers Dis. 2021. PMID: 33720890 Free PMC article.
-
Postoperative changes in ventricular cerebrospinal fluid biomarkers with correlation to clinical outcome in idiopathic normal pressure hydrocephalus.J Alzheimers Dis. 2025 Aug;106(3):1036-1048. doi: 10.1177/13872877251350308. Epub 2025 Jun 20. J Alzheimers Dis. 2025. PMID: 40538200 Free PMC article.
-
Cerebrospinal fluid biomarkers that reflect clinical symptoms in idiopathic normal pressure hydrocephalus patients.Fluids Barriers CNS. 2022 Feb 5;19(1):11. doi: 10.1186/s12987-022-00309-z. Fluids Barriers CNS. 2022. PMID: 35123528 Free PMC article.
-
Cerebrospinal Fluid Biomarkers in Idiopathic Normal Pressure Hydrocephalus versus Alzheimer's Disease and Subcortical Ischemic Vascular Disease: A Systematic Review.J Alzheimers Dis. 2019;68(1):267-279. doi: 10.3233/JAD-180816. J Alzheimers Dis. 2019. PMID: 30741681
-
Cerebrospinal fluid and venous biomarkers of shunt-responsive idiopathic normal pressure hydrocephalus: a systematic review and meta-analysis.Acta Neurochir (Wien). 2022 Jul;164(7):1719-1746. doi: 10.1007/s00701-022-05154-5. Epub 2022 Mar 1. Acta Neurochir (Wien). 2022. PMID: 35230552 Free PMC article.
References
-
- Adams RD, et al. Symptomatic occult hydrocephalus with normal cerebrospinal-fluid pressure. A treatable syndrom. N Engl J Med. 1965;273:117–26. - PubMed
-
- Marmarou A, et al. Guidelines for management of idiopathic normal pressure hydrocephalus: progress to date. Acta Neurochir Suppl. 2005;95:237–40. - PubMed
-
- Klinge P, Hellstrom P, Tans J, Wikkelso C. One-year outcome in the European multicentre study on iNPH. Acta Neurol Scand. 2012;126(3):145–53. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous